
Construction begins on our amazing new Radiation Oncology and Pathology building in Duarte slated to open in early 2029!
✓Professor, National Chair of Radiation Oncology @ City of Hope (CA, IL, GA, AZ), husband, father, #PhysicianScientist, #Radbio, thoracic/HPB cancers, views=own

Construction begins on our amazing new Radiation Oncology and Pathology building in Duarte slated to open in early 2029!

A truly invigorating and fun filled day! Thank you to our hospital leaders, departmental speakers, moderators, and our inspiring keynote speaker, CMO from @UCSDHealth @catherynyashar ! Also loved the LEGO team-building event crafted by Dr. Gomez!

Huge congrats to @HMcGeeMDPhD and her team on this exciting @NatureComms publication detailing a how RT shifts anti-inflammatory ILC2s toward pro-inflammatory ILC1 through T1 IFN signaling. Blocking T1 IFN reduces lung damage representing a novel opportunity for intervention! 👏

PainterDebate going on now at RRS2026❗️Fun discussion whether 🐁models are relevant to ☢️research (@DKirschMDPhD), or should they go the way of the Dodo (JacobScott). Who will win? Certainly Dr. Kitsch wins points for costume! #radbio #rrs

Great work by @cui_tiantian on a simple project of repurposing an antibiotic to reduce stemness and sensitize breast cancer cells to ☢️. Lets see if we can test this out some more! #radbio #RRS

Congratulations Dr. Daroui! We are proud!

Well done @lauren_henke @PercyLeeMD @TamerRefaatMD. Great topic of discussion and much to sort out regarding the nuances of the platforms! 👍

New clinical trial data from Jeremy Brownstein evaluating a hypoxic radiosensitizer in combination with lung SBRT. #ASTRO26 1/

Our own Dr. Sean Maroongroge presenting on national Medicare claims trends on IV RPT, showing increase >20-fold over the last decade, with increases in RadOnc and NucMed/Radiology activity. Conclusions include we need to work together to scale & meet growing patient need! 📈💉

From advanced imaging in rectal cancer to radiopharmaceutical therapy trends and innovative breast cancer treatment approaches, @COH_RadOnc is proud to contribute to the science featured at #ASTRO26 next week! #radbio #theranostics #breastcancer

It was a true pleasure to host Dr. Vivek Kavadi, @ASTRO_org CEO, for a visit @cityofhope, and hear about his vision. Great discussions centered on the changing landscape of reimbursement & payment reform, headwinds in #radonc research, future specialty growth & much more❗️👍

Her trailblazing work aims to advance immunotherapy/RPT combinations in prostate cancer. Very excited for this project!! #VFoundation #CancerResearch #RadioligandTherapy #RPT x.com/TeWilliamsMD/status/20…

Congrats to Dr. Rose Li on receiving a V Foundation Award for her groundbreaking project, “Exploring Immune Activation with ¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC)” funded over the next four years.

Congratulations to Dr. Parima Daroui on being named an ASTRO Fellow (#FASTRO)! This prestigious honor recognizes her outstanding contributions to radiation oncology and dedication to advancing patient care. Well done Parima! @ASTRO_org #RadOnc x.com/TeWilliamsMD/status/20…

Physician Highlight: Dr. Benjamin Cahan, Medical Director of Radiation Oncology at Mission Hills, delivers high-quality care in the San Fernando Valley. He specializes in advanced therapies including brachytherapy, combining cutting-edge treatment with compassionate care.

Congratulations to Dr. Rose Li on receiving a V Foundation Award: Exploring Immune Activation with 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC)— evaluating the combination of 177Lu-PSMA-617 with biospecific T-cell engagers.